Aurobindo Pharma gets approval for acquisition of business and certain assets of Veritaz

29 Mar 2022 Evaluate

Aurobindo Pharma has received an approval for the acquisition of business and certain assets of Veritaz Healthcare (Veritaz). Veritaz operates in pharmaceutical industry in India and sells branded generic formulations and other health care related products. Accordingly, the Company has entered into a definitive agreement under which the Company will acquire business and certain assets from Veritaz.

The Board of Directors of the Company at its meeting held on March 28, 2022 has approved the same.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1224.75 14.85 (1.23%)
19-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.10
Dr. Reddys Lab 1278.90
Cipla 1517.00
Zydus Lifesciences 919.85
Lupin 2125.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×